GSA CAPITAL PARTNERS LLP - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$529,000
-63.4%
7,769
-84.3%
0.07%
-61.3%
Q4 2021$1,444,000
-14.7%
49,327
-25.7%
0.18%
+5.2%
Q3 2021$1,692,000
+635.7%
66,402
+910.4%
0.17%
+561.5%
Q2 2021$230,000
-17.6%
6,572
+14.2%
0.03%
-31.6%
Q3 2019$279,000
+22.9%
5,756
+33.9%
0.04%
+65.2%
Q1 2019$227,000
+25.4%
4,298
-60.6%
0.02%
+130.0%
Q2 2016$181,00010,9000.01%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q2 2019
NameSharesValueWeighting ↓
Fernwood Investment Management, LLC 355,509$17,171,0009.58%
Perceptive Advisors 4,989,066$240,971,0006.75%
GREAT POINT PARTNERS LLC 736,631$35,579,000,0005.28%
Casdin Capital, LLC 600,000$28,980,0005.10%
Avoro Capital Advisors LLC 1,765,548$85,276,0004.07%
Iguana Healthcare Management, LLC 115,000$5,555,0003.65%
Camber Capital Management LP 1,200,000$57,960,0002.85%
NEXTHERA CAPITAL LP 315,147$15,222,0002.51%
RTW INVESTMENTS, LP 456,921$22,069,0002.10%
EMORY UNIVERSITY 41,610$2,010,0001.44%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders